Arteris, Inc. (NASDAQ:AIP) VP Paul L. Alpern Sells 3,615 Shares

Arteris, Inc. (NASDAQ:AIPGet Free Report) VP Paul L. Alpern sold 3,615 shares of the business’s stock in a transaction dated Friday, July 5th. The shares were sold at an average price of $7.18, for a total value of $25,955.70. Following the completion of the sale, the vice president now owns 74,563 shares in the company, valued at $535,362.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Arteris Stock Up 3.3 %

Shares of NASDAQ:AIP traded up $0.25 during midday trading on Tuesday, reaching $7.87. The company had a trading volume of 152,330 shares, compared to its average volume of 191,300. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 0.11. The business’s 50 day moving average price is $7.88 and its 200 day moving average price is $7.01. The stock has a market cap of $302.84 million, a PE ratio of -7.64 and a beta of 1.11. Arteris, Inc. has a 1-year low of $4.20 and a 1-year high of $9.54.

Arteris (NASDAQ:AIPGet Free Report) last released its earnings results on Thursday, May 2nd. The company reported ($0.24) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.03. The business had revenue of $12.95 million for the quarter, compared to the consensus estimate of $12.60 million. Arteris had a negative return on equity of 198.35% and a negative net margin of 69.70%. Research analysts forecast that Arteris, Inc. will post -0.91 EPS for the current fiscal year.

Institutional Trading of Arteris

Hedge funds and other institutional investors have recently modified their holdings of the stock. Victory Capital Management Inc. acquired a new position in Arteris during the fourth quarter worth approximately $60,000. Citigroup Inc. acquired a new position in Arteris during the third quarter worth approximately $363,000. Worth Venture Partners LLC increased its position in Arteris by 114.3% during the fourth quarter. Worth Venture Partners LLC now owns 109,921 shares of the company’s stock worth $647,000 after buying an additional 58,620 shares during the last quarter. GSA Capital Partners LLP grew its position in shares of Arteris by 26.9% in the first quarter. GSA Capital Partners LLP now owns 132,952 shares of the company’s stock valued at $973,000 after purchasing an additional 28,165 shares during the last quarter. Finally, Acuitas Investments LLC grew its position in shares of Arteris by 150.3% in the fourth quarter. Acuitas Investments LLC now owns 215,991 shares of the company’s stock valued at $1,272,000 after purchasing an additional 129,692 shares during the last quarter. Institutional investors and hedge funds own 64.36% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Rosenblatt Securities restated a “buy” rating and issued a $15.00 price target on shares of Arteris in a report on Friday, May 3rd. Jefferies Financial Group restated a “hold” rating and issued a $9.00 price target (down from $11.00) on shares of Arteris in a report on Monday, May 13th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $13.40.

Read Our Latest Research Report on AIP

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Articles

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.